24小时热门版块排行榜

返回列表

runliangfeng

木虫 (正式写手)

应助: 1 (幼儿园)
金币: 1864.9
红花: 5
帖子: 546
在线: 70.1小时
虫号: 2852927
注册: 2013-12-06
性别: GG
专业: 仿生材料

[调剂信息] 济南大学宋老师招收生物学学硕调剂生

考研调剂招生信息

学校:	济南大学
专业:	理学->生物学->微生物学
年级:	2024
招生人数:	1
招生状态:	正在招生中
联系方式:	********* (为保护个人隐私,联系方式仅限APP查看)

补充内容

宋老师所在学院为生物科学与技术学院，主要从事新型药物制剂、药用高分子材料及抗肿瘤药物、抗微生物药物纳米靶向载药系统等的设计及开发研究，研究内容涉及药学、化学、生物学等相关学科，具有十分明显的学科交叉性质。
欢迎有药学、制药、化学、生物等相关背景的同学参加本课题组调剂招生。
联系方式：
qq 281081550
E-mail: 281081550@qq.com
联系人：宋老师
1) Zhimei SONG, Zhu Li, Xu Hongmei, Wen Yi, Feng Runliang*. Phenylboronic acid-installed poly(isobutene-alt-maleic anhydride) polymeric micelles for pH-dependent release of amphotericin B. Journal of Drug Delivery Science and Technology, 2023 81: 104225.
2) Feng Runliang, Zhu Li, Teng Fangfang, Wang Min, Chen Shiyu, Song Zhimei*, Li Hongmei**. Phenylboronic acid-modified polymaleic anhydride-F127 micelles for pH-activated targeting delivery of doxorubicin." Colloids and Surfaces B: Biointerfaces, 2022, 216: 112559
3) Song Zhimei, Wen Yi, Teng Fangfang, Wang Min, Liu Na, Feng Runliang*. Carbopol 940 hydrogel containing curcumin-loaded micelles for skin delivery and application in inflammation treatment and wound healing. New Journal of Chemistry, 2022, 46(8): 3674-3686.
4) Runliang Feng, Wanqiu Wang, Li Zhu, Hongmei Xu, Shiyu Chen, Zhimei Song*. Phenylboronic acid‐functionalized F127-oligochitosan conjugate micelles for doxorubicin encapsulation. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2020, 108(8): 3345-3355
5) Hongmei Xu, Yi Wen, Shiyu Chen, Li Zhu, Runliang Feng*, Zhimei Song*. Paclitaxel skin delivery by micelles-embedded Carbopol 940 hydrogel for local therapy of melanoma. International Journal of Pharmaceutics, 2020, 587: 119626
6) Zhimei Song, Yi Wen, Peizong Deng, Fangfang Teng, Feilong Zhou, Hongmei Xu, Sijia Feng, Li Zhu, Runliang Feng*. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. Carbohydrate Polymers, 2019, 205: 571-580.
7) Zhimei Song, Jingjie Sun, Peizong Deng, Feilong Zhou, Hongmei Xu, Yi Wen. Fangfang Teng, Di Ge, Runliang Feng*, Oligochitosan-pluronic 127 conjugate for delivery of honokiol, Artificial cells, nanomedicine, and Biotechnology, 2018, 46(sup1): 740-750 (SCI, IF=4.462)
8) Runliang Feng, Wenxia Zhu, Wei Chu, Fangfang Teng, Ning Meng, Peizong Deng, Zhimei Song *. Y-shaped folic acid-conjugated PEG-PCL copolymeric micelles for delivery of curcumin. Anti-Cancer Agents in Medicinal Chemistry, 2017, 4: 599-607 (SCI, IF=2.556)
9) Zhimei Song, Peizong Deng, Fangfang Teng, Feilong Zhou, Wenxia Zhu, Runliang Feng*. Development on PEG-modified Poly (Amino Acid) Copolymeric Micelles for Delivery of Anticancer Drug. Anti-Cancer Agents in Medicinal Chemistry 2017, 17(6): 784-801. (SCI, IF=2.556)
10) Zhimei Song, Wenxia Zhu, Jiarong Song, Peng Wei, Fengying Yang, Na Liu, Runliang Feng*, Linear-dendrimer Type Methoxy-poly (ethylene glycol)–b-poly (-caprolactone) Copolymer Micelles for the Delivery of Curcumin, Drug Delivery, 2015, 22(1): 58-68 (SCI, IF=4.843)
11) Zhimei Song, Wenxia Zhu, Fengying Yang, Na Liu, Runliang Feng*, Preparation, characterization, in vitro release, and pharmacokinetic studies of curcumin-loaded mPEG–PVL nanoparticles, Polymer Bulletin, 2015, 72: 75-91(SCI, IF=1.371)
12) Zhimei Song, Wenxia Zhu, Na Liu, Fengying Yang, Runliang Feng*, Linolenic acid-modified PEG-PCL micelles for curcumin delivery, International Journal of Pharmaceutics, 2014, 471: 312-321(SCI, IF=3.785)
13) Runliang Feng, Wenxia Zhu, Zhimei Song*, Liyan Zhao, Guangxi Zhai, Novel star-type methoxy-poly(ethylene glycol) (PEG)–poly(e-caprolactone) (PCL) copolymeric nanoparticles for controlled release of curcumin, Journal of Nanoparticle Research, 2013, 15: 1748-1759 (SCI, IF=2.175)
14) Zhimei Song#, Runliang Feng#, Min Sun, Chenyu Guo, Yan Gao, Lingbing Li, Guangxi Zhai*. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo, Journal of Colloid and Interface Science, 2011, 354: 116–123(SCI, IF=3.066)

回复此楼